HP 10-K/A 2022-10-31

Filed 2023-09-11. 4 sections, 376K characters. Original on sec.gov · Markdown · JSON

What changed since the 2019-10-31 10-K/ANew, removed and reworded risk factor headings, then every item sentence by sentence.

Cover and table of contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

(Amendment Number 1)

(Mark One)
☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended
October 31, 2022
Or
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number
1-4423

HP Inc.

(Exact name of registrant as specified in its charter)

Delaware94-1081436
(State or other jurisdiction of incorporation or organization)(I.R.S. employer identification no.)
1501 Page Mill Road94304
Palo Alto, California(Zip code)
(Address of principal executive offices)

(650) 857-1501

(Registrant’s telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.01 per shareHPQNew York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act

Large accelerated filer☒Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The aggregate market value of the registrant’s common stock held by non-affiliates was $37,840,980,837 based on the last sale price of common stock as of April 30, 2022.

The number of shares of HP Inc. common stock outstanding as of November 30, 2022 was 982,145,796 shares.

DOCUMENTS INCORPORATED BY REFERENCE
DOCUMENT DESCRIPTION10-K/A PART
Portions of the Registrant’s definitive proxy statement related to its 2023 Annual Meeting of Stockholders to be filed pursuant to Regulation 14A within 120 days after Registrant’s fiscal year end of October 31, 2022 are incorporated by reference into Part III of this Report.III

Explanatory Note

HP Inc. (“HP,” the “Company,” “we,” “us,” and “our”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment") to our Annual Report on Form 10-K for the fiscal year ended October 31, 2022, which was filed with the Securities and Exchange Commission (the “SEC”) on December 6, 2022 (the “Original Form 10-K”) to make certain changes, as described below.

In connection with the preparation of HP’s Consolidated Condensed Financial Statements for the three and nine months ended July 31, 2023, the Company identified an accounting error related to a revenue contract in the Personal Systems segment. We evaluated the materiality of the error and concluded that it did not result in a material misstatement of our previously issued Consolidated Financial Statements.

However, in connection with the period-end close process, we identified material weaknesses in the Company’s internal control over financial reporting and have concluded these material weaknesses were present as of October 31, 2022. For a more detailed description of these material weaknesses, refer to Part II, Item 9A,“Controls and Procedures.” This Amendment revises our assessment of the effectiveness of our internal control over financial reporting and our disclosure controls and procedures to indicate that they were not effective as of October 31, 2022 because of these material weaknesses. A revised opinion from our independent registered public accounting firm, Ernst & Young LLP, on our internal control over financial reporting as of October 31, 2022 also is included with this Amendment.

This Amendment also revises our previously issued Consolidated Financial Statements for the fiscal years ended 2022 2021, and 2020. In connection with the revisions for this error, the Company has also corrected the timing of other unrelated immaterial errors which were previously made in the periods the Company identified them.

“Forward-Looking Statements” of Part I of the Original Form 10-K and Item 8, “Financial Statements and Supplementary Data” and Item 9A, “Controls and Procedures,” of Part II of the Original Form 10-K are hereby deleted in their entireties and replaced with “Forward-Looking Statements,” Item 8, and Item 9A included herein. Item 15, “Exhibits and Financial Statement Schedules,” of Part IV of the Original Form 10-K also has been amended to include a new consent of Ernst & Young LLP and, as required by Rule 12b-15 under the Securities Act of 1934, as amended, to provide new currently dated certifications by our Chief Executive Officer and Chief Financial Officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002. The new consent is attached to this Amendment as Exhibit 23 and the new certifications are attached to this Amendment as Exhibits 31.1, 31.2, and 32.

The only changes to the Original Form 10-K are those related to the matters described above. Except as described above, this Amendment does not amend, update, or change any other item or disclosure in the Original Form 10-K and does not purport to reflect any information or event subsequent to the filing thereof. As such, this Amendment speaks only as of the date the Original Form 10-K was filed, and the Company has not undertaken herein to amend, update, or change any information contained in the Original Form 10-K to give effect to any subsequent event, other than as expressly indicated in this Amendment. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and any subsequent filing with the SEC.

HP INC. AND SUBSIDIARIES

Form 10-K/A

For the Fiscal Year ended October 31, 2022

Table of Contents

Page
Forward-Looking Statements3
PART II
Item 8.Financial Statements and Supplementary Data6
Item 9A.Controls and Procedures78
PART IV
Item 15.Exhibits and Financial Statement Schedules79

Forward-Looking Statements

The Original Form 10-K, as amended by this Amendment, including “Business” in Item 1 and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7, contains forward-looking statements based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, they could affect the business and results of operations of HP Inc. and its consolidated subsidiaries (“HP”) which may differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including, but not limited to, any statements regarding the impact of the COVID-19 pandemic; projections of net revenue, margins, expenses, effective tax rates, net earnings, net earnings per share, cash flows, benefit plan funding, deferred taxes, share repurchases, foreign currency exchange rates or other financial items; any projections of the amount, timing or impact of cost savings or restructuring and other charges, planned structural cost reductions and productivity initiatives; any statements of the plans, strategies and objectives of management for future operations, including, but not limited to, our business model and transformation, our sustainability goals, our go-to-market strategy, the execution of restructuring plans and any resulting cost savings (including the fiscal 2023 plan), net revenue or profitability improvements or other financial impacts; any statements concerning the expected development, demand, performance, market share or competitive performance relating to products or services; any statements concerning potential supply constraints, component shortages, manufacturing disruptions or logistics challenges; any statements regarding current or future macroeconomic trends or events and the impact of those trends and events on HP and its financial performance; any statements regarding pending investigations, claims, disputes or other litigation matters; any statements of expectation or belief as to the timing and expected benefits of acquisitions and other business combination and investment transactions (including the recent acquisition of Plantronics, Inc. (“Poly”)); and any statements of assumptions underlying any of the foregoing.

Forward-looking statements can also generally be identified by words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” and similar terms.

Risks, uncertainties and assumptions that could affect our business and results of operations include factors relating to:

  • the impact of macroeconomic and geopolitical trends, changes and events, including the Russian invasion of Ukraine and tension across the Taiwan Strait and the regional and global ramifications of these events;

  • recent volatility in global capital markets, increases in benchmark interest rates, the effects of inflation and instability of financial institutions;

  • risks associated with HP’s international operations; the effects of the COVID-19 pandemic;

  • the execution and performance of contracts by HP and its suppliers, customers, clients and partners, including logistical challenges with respect to such execution and performance;

  • changes in estimates and assumptions HP makes in connection with the preparation of its financial statements;

  • the need to manage (and reliance on) third-party suppliers, including with respect to component shortages, and the need to manage HP’s global, multi-tier distribution network, limit potential misuse of pricing programs by HP’s channel partners, adapt to new or changing marketplaces and effectively deliver HP’s services;

  • HP’s ability to execute on its strategic plans, including the previously announced initiatives, business model changes and transformation;

  • execution of planned structural cost reductions and productivity initiatives;

  • HP’s ability to complete any contemplated share repurchases, other capital return programs or other strategic transactions;

  • the competitive pressures faced by HP’s businesses;

  • risks associated with executing HP’s strategy and business model changes and transformation;

  • successfully innovating, developing and executing HP’s go-to-market strategy, including online, omnichannel and contractual sales, in an evolving distribution, reseller and customer landscape;

  • the development and transition of new products and services and the enhancement of existing products and services to meet evolving customer needs and respond to emerging technological trends;

  • successfully competing and maintaining the value proposition of HP’s products, including supplies;

  • challenges to HP’s ability to accurately forecast inventories, demand and pricing, which may be due to HP’s multi-tiered channel, sales of HP’s products to unauthorized resellers or unauthorized resale of HP’s products or our uneven sales cycle;

  • integration and other risks associated with business combination and investment transactions;

  • the results of our restructuring plans (including the fiscal 2023 plan), including estimates and assumptions related to the cost (including any possible disruption of HP’s business) and the anticipated benefits of our restructuring plans;

  • the protection of HP’s intellectual property assets, including intellectual property licensed from third parties;

  • the hiring and retention of key employees;

  • disruptions in operations from system security risks, data protection breaches, cyberattacks, extreme weather conditions or other effects of climate change, medical epidemics or pandemics such as the COVID-19 pandemic, and other natural or manmade disasters or catastrophic events;

  • the impact of changes to federal, state, local and foreign laws and regulations, including environmental regulations and tax laws;

  • our aspirations related to environmental, social and governance matters;

  • potential impacts, liabilities and costs from pending or potential investigations, claims and disputes;

  • the effectiveness of our internal control over financial reporting; and

  • other risks that are described herein and in the Original Form 10-K, including but not limited to the items discussed in “Risk Factors” in Item 1A of Part I of the Original Form 10-K and that are otherwise described or updated from time to time in HP’s other filings with the Securities and Exchange Commission (the “SEC”).

Forward-looking and other statements in this report may also address our corporate sustainability or responsibility progress, plans, and goals (including environmental matters), and the inclusion of such statements is not an indication that these contents are necessarily material to investors or required to be disclosed in HP’s filings with the SEC. In addition, historical, current, and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.

The forward-looking statements in this report are made as of the date of this filing and HP assumes no obligation and does not intend to update these forward-looking statements.

PART II

Item 8. Financial Statements and Supplementary Data.

Table of Contents

Page
Reports of Independent Registered Public Accounting Firm (PCAOB ID: 42)7
Management's Report on Internal Control Over Financial Reporting10
Consolidated Statements of Earnings11
Consolidated Statements of Comprehensive Income12
Consolidated Balance Sheets13
Consolidated Statements of Cash Flows14
Consolidated Statements of Stockholders’ Deficit15
Notes to Consolidated Financial Statements16
Note 1: Summary of Significant Accounting Policies16
Note 2: Segment Information23
Note 3: Restructuring and Other Charges28
Note 4: Retirement and Post-Retirement Benefit Plans29
Note 5: Stock-Based Compensation37
Note 6: Taxes on Earnings41
Note 7: Supplementary Financial Information45
Note 8: Goodwill and Intangible Assets50
Note 9: Fair Value51
Note 10: Financial Instruments54
Note 11: Borrowings59
Note 12: Stockholders’ Deficit62
Note 13: Net Earnings Per Share64
Note 14: Litigation and Contingencies65
Note 15: Guarantees, Indemnifications and Warranties68
Note 16: Commitments69
Note 17: Leases70
Note 18: Acquisitions72
Note 19: Revision of Prior Period Consolidated Financial Statements74

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of Directors of HP Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of HP Inc. and subsidiaries (the Company) as of October 31, 2022 and 2021, the related consolidated statements of earnings, comprehensive income, stockholders' deficit and cash flows for each of the three years in the period ended October 31, 2022, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at October 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended October 31, 2022, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of October 31, 2022, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated December 6, 2022, except for the effect of the material weaknesses described in the fourth paragraph of that report, as to which the date is September 11, 2023, expressed an adverse opinion thereon.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

Income Taxes
Description of the MatterAs described in Notes 1 and 6 of the consolidated financial statements, the Company is subject to income taxes in the United States and several other countries and is subject to routine corporate income tax audits in many of those jurisdictions. Uncertainty in the Company’

Showing the first 8K of 310K characters. Open the full section

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report (the “Evaluation Date”). At the time that the Form 10-K for our fiscal year ended October 31, 2022 was filed on December 6, 2022, our principal executive officer and principal financial officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective such that the information required to be disclosed by us in our SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to HP’s management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Subsequent to this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of the Evaluation Date due to the material weaknesses in our internal control over financial reporting described below.

See Management’s Report on Internal Control over Financial Reporting and the Report of Independent Registered Public Accounting Firm on our internal control over financial reporting in Item 8, which are incorporated herein by reference.

Remediation Plan for the Material Weaknesses

The Company’s management, under the oversight of the Audit Committee, is in the process of designing prevent and detect controls specific to the impacted business activity.

The Company’s management is also enhancing its processes and controls to help ensure the timely review of the SOC-1 report in conjunction with designing and implementing related, effective complementary user entity controls associated with the sales incentive payment processing application.

While we have taken steps to implement our remediation plan, the material weaknesses will not be considered remediated until the enhanced controls operate for a sufficient period of time and management has concluded, through testing, that the related controls are effective. The Company will monitor the effectiveness of its remediation plan and refine its remediation plan as appropriate.

Changes in Internal Control over Financial Reporting

As described above, we are taking steps to remediate the material weaknesses in our internal control over financial reporting. Other than in connection with the remediation process described above, no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART IV

Item 15. Exhibits and Financial Statement Schedules.

(a)The following documents are filed as part of this report:

1.All Financial Statements:

The following financial statements are filed as part of this report under Item 8—“Financial Statements and Supplementary Data.”

Reports of Independent Registered Public Accounting Firm7
Management's Report on Internal Control Over Financial Reporting10
Consolidated Statements of Earnings11
Consolidated Statements of Comprehensive Income12
Consolidated Balance Sheets13
Consolidated Statements of Cash Flows14
Consolidated Statements of Stockholders' Deficit15
Notes to Consolidated Financial Statements16

2.Financial Statement Schedules:

All schedules are omitted as the required information is not applicable or the information is presented in the Consolidated Financial Statements and notes thereto in Item 8 above.

3.Exhibits:

HP INC. AND SUBSIDIARIES

EXHIBIT INDEX

h

Exhibit NumberIncorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
2(a)Separation and Distribution Agreement, dated as of October 31, 2015, by and among Hewlett-Packard Company, Hewlett Packard Enterprise Company and the Other Parties Thereto.**8-K001-044232.1November 5, 2015
2(b)Transition Services Agreement, dated as of November 1, 2015, by and between Hewlett-Packard Company and Hewlett Packard Enterprise Company.**8-K001-044232.2November 5, 2015
2(c)Employee Matters Agreement, dated as of October 31, 2015, by and between Hewlett-Packard Company and Hewlett Packard Enterprise Company.**8-K001-044232.4November 5, 2015
3(a)Registrant’s Certificate of Incorporation.10-Q001-044233(a)June 12, 1998
3(b)Registrant’s Amendment to the Certificate of Incorporation.10-Q001-044233(b)March 16, 2001
Exhibit NumberIncorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
3(c)Registrant’s Certificate of Amendment to the Certificate of Incorporation.8-K001-044233.2October 22, 2015
3(d)Registrant’s Certificate of Amendment to the Certificate of Incorporation.8-K001-044233.1April 7, 2016
3(e)Registrant’s Amended and Restated Bylaws.8-K001-044233.1February 13, 2019
3(f)Certificate of Designations of Series A Junior Participating Preferred Stock of HP Inc.8-K001-044233.1February 20, 2020
4(a)Form of Senior IndentureS-3333-2151164.1December 15, 2016
4(b)Form of Subordinated Indenture.S-3333-2151164.2December 15, 2016
4(c)Form of Registrant’s 4.375% Global Note due September 15, 2021 and 6.000% Global Note due September 15, 2041 and form of related Officers’ Certificate.8-K001-044234.4, 4.5 and 4.6September 19, 2011
4(d)Form of Registrant’s 4.650% Global Note due December 9, 2021 and related Officers’ Certificate.8-K001-044234.3 and 4.4December 12, 2011
4(e)Form of Registrant’s 4.050% Global Note due September 15, 2022 and related Officers’ Certificate.8-K001-044234.2 and 4.3March 12, 2012
4(f)Specimen certificate for the Registrant’s common stock.8-A/A001-044234.1June 23, 2006
4(g)First Supplemental Indenture, dated as of March 26, 2018, to the Indenture, dated as of June 1, 2000, by and between the Registrant and The Bank of New York Mellon Trust Company, N.A.10-Q001-044234(j)June 5, 2018
4(h)Description of HP Inc.’s securities.10-K001-044234(j)December 12, 2019
4(i)Indenture, dated as of June 17, 2020, between HP Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee.8-K001-044234.1June 17, 2020
4(j)Form of 2.200% notes due 2025 and related Officers’ Certificate.8-K001-044234.2 and 4.5June 17, 2020
4(k)Form of 3.000% notes due 2027 and related Officers’ Certificate.8-K001-044234.3 and 4.5June 17, 2020
4(l)Form of 3.400% notes due 2030 and related Officers’ Certificate.8-K001-044234.4 and 4.5June 17, 2020
4(m)First Supplemental Indenture, dated as of June 16, 2021, between the Registrant and The Bank of New York Mellon Trust Company, N.A., as Trustee.8-K001-044234.2June 21, 2021
4(n)Registration Rights Agreement, dated as of June 16, 2021, by and among the Registrant and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the Initial Purchasers of the Notes.8-K001-044234.3June 21, 2021
4(o)Form of 4.000% notes due 2029 and related Officers’ Certificate.8-K001-044234.2 and 4.4March 31, 2022
4(p)Form of 4.200% notes due 2032 and related Officers’ Certificate.8-K001-044234.3 and 4.4March 31, 2022
4(q)Form of 4.750% notes due 2028 and related Officers’ Certificate.8-K001-044234.2 and 4.4June 21, 2022
4(r)Form of 5.500% notes due 2033 and related Officers’ Certificate.8-K001-044234.3 and 4.4June 21, 2022
4(s)Second Supplemental Indenture, dated as of September 1, 2022, between HP Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee.8-K001-044234.2September 7, 2022
Exhibit NumberIncorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
10(a)Registrant’s 2004 Stock Incentive Plan.*S-8333-1142534.1April 7, 2004
10(b)Registrant’s Excess Benefit Retirement Plan, amended and restated as of January 1, 2006.*8-K001-0442310.2September 21, 2006
10(c)Hewlett-Packard Company Cash Account Restoration Plan, amended and restated as of January 1, 2005.*8-K001-0442399.3November 23, 2005
10(d)Form of Agreement Regarding Confidential Information and Proprietary Developments (California).*8-K001-0442310.2January 24, 2008
10(e)Form of Agreement Regarding Confidential Information and Proprietary Developments (Texas).*10-Q001-0442310(o)(o)March 10, 2008
10(f)Form of Stock Option Agreement for Registrant’s 2004 Stock Incentive Plan.*10-Q001-0442310(p)(p)March 10, 2008
10(g)Form of Common Stock Payment Agreement for Registrant’s 2000 Stock Plan.*10-Q001-0442310(u)(u)June 6, 2008
10(h)First Amendment to the Hewlett-Packard Company Excess Benefit Retirement Plan.*10-Q001-0442310(b)(b)(b)March 10, 2009
10(i)Form of Stock Notification and Award Agreement for awards of non-qualified stock options.*10-K001-0442310(i)(i)(i)December 15, 2010
10(j)Form of Agreement Regarding Confidential Information and Proprietary Developments (California—new hires).*10-K001-0442310(j)(j)(j)December 15, 2010
10(k)Form of Agreement Regarding Confidential Information and Proprietary Developments (California—current employees).*10-K001-0442310(k)(k)(k)December 15, 2010
10(1)Second Amended and Restated Hewlett-Packard Company 2004 Stock Incentive Plan, as amended effective February 28, 2013.*8-K001-0442310.2March 21, 2013
10(m)Form of Stock Notification and Award Agreement for awards of foreign stock appreciation rights.*10-Q001-0442310(v)(v)March 11, 2014
10(n)Form of Stock Notification and Award Agreement for long-term cash awards.*10-Q001-0442310(w)(w)March 11, 2014
10(o)Form of Stock Notification and Award Agreement for awards of non-qualified stock options.*10-Q001-0442310(x)(x)March 11, 2014
10(p)Form of Stock Notification and Award Agreement for awards of performance-contingent non-qualified stock options.*10-Q001-0442310(a)(a)(a)March 11, 2014
10(q)Form of Grant Agreement for grants of performance-contingent non-qualified stock options.*10-Q001-0442310(b)(b)(b)March 11, 2014
10(r)Form of Grant Agreement for grants of long-term cash awards.*10-Q001-0442310(e)(e)(e)March 11, 2015
10(s)Form of Grant Agreement for grants of non-qualified stock options.*10-Q001-0442310(f)(f)(f)March 11, 2015
10(t)Form of Grant Agreement for grants of performance-contingent non-qualified stock options.*10-Q001-0442310(i)(i)(i)March 11, 2015
10(u)Form of Grant Agreement for grants of foreign stock appreciation rights.*10-K001-0442310(e)(e)(e)December 16, 2015
10(v)Form of Grant Agreement for grants of performance-contingent non-qualified stock options.*10-K001-0442310(f)(f)(f)December 16, 2015
10(w)Form of Grant Agreement for grants of non-qualified stock options.*10-K001-0442310(g)(g)(g)December 16, 2015
Exhibit NumberIncorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
10(x)Registrant’s 2005 Executive Deferred Compensation Plan, amended and restated effective November 1, 2017.*10-K/A001-0442310(n)(n)December 15, 2017
10(y)Registrant’s Severance and Long-Term Incentive Change in Control Plan for Executive Officers, amended and restated effective February 28, 2020.*10-Q001-0442310(p)(p)March 5, 2020
10(z)Form of Stock Notification and Award Agreement for awards of performance-contingent non-qualified stock options (launch grant).*10-Q001-0442310(p)(p)March 3, 2016
10(a)(a)2017 Amendment to the Hewlett-Packard Company Cash Account Restoration Plan.*10-Q001-0442310(w)(w)March 2, 2017
10(b)(b)Second Amendment to the Hewlett-Packard Company Excess Benefit Retirement Plan.*10-Q001-0442310(x)(x)March 2, 2017
10(c)(c)Second Amended and Restated HP Inc. 2004 Stock Incentive Plan, as amended and restated effective January 23, 2017.*10-Q001-0442310(y)(y)March 2, 2017
10(d)(d)Second Amended and Restated HP Inc. 2004 Stock Incentive Plan (as amended effective January 29, 2018).*10-Q001-0442310(b)(b)(b)March 1, 2018
10(e)(e)Form of Grant Agreement for grants of restricted stock units (for use from November 1, 2017).*10-Q001-0442310(c)(c)(c)March 1, 2018
10(f)(f)Form of Grant Agreement for grants of restricted stock units for directors (for use from November 1, 2017).*10-Q001-0442310(e)(e)(e)March 1, 2018
10(g)(g)Form of Grant Agreement for grants of stock options for directors (for use from November 1, 2017).*10-Q001-0442310(f)(f)(f)March 1, 2018
10(h)(h)Form of Grant Agreement for grants of restricted stock units (for use from November 1, 2018).*10-K001-0442310(g)(g)(g)December 13, 2018
10(i)(i)Form of Grant Agreement for grants of performance-adjusted restricted stock units (for use from November 1, 2018).*10-K001-0442310(h)(h)(h)December 13, 2018
10(j)(j)Form of Grant Agreement for grants of stock options for directors (for use from November 1, 2018).*10-Q001-0442310(j)(j)(j)March 5, 2019
10(k)(k)Form of Grant Agreement for grants of restricted stock units for directors (for use from November 1, 2018).*10-Q001-0442310(k)(k)(k)March 5, 2019
10(l)(l)Form of Grant Agreement for grants of restricted stock units (for use from July 1, 2019).*10-Q001-0442310(l)(l)(l)August 29, 2019
10(m)(m)Form of Grant Agreement for grants of non-qualified stock options.*10-K001-0442310(m)(m)(m)December 12, 2019
10(n)(n)Form of Retention Grant Agreement for grants of non-qualified stock options.*10-K001-0442310(n)(n)(n)December 12, 2019
Exhibit NumberIncorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
10(o)(o)Form of Grant Agreement for grants of stock options for directors (for use from January 15, 2020).*10-Q001-0442310(m)(m)(m)March 5, 2020
10(p)(p)Form of Grant Agreement for grants of restricted stock units for directors (for use from January 15, 2020).*10-Q001-0442310(n)(n)(n)March 5, 2020
10(q)(q)Form of Retention Grant Agreement for grants of restricted stock units (for use from November 1, 2019).*10-Q001-0442310(o)(o)(o)March 5, 2020
10(r)(r)Form of Grant Agreement for grants of restricted stock units (for use from November 1, 2019).*10-Q001-0442310(p)(p)(p)March 5, 2020
10(s)(s)Form of Grant Agreement for grants of performance-adjusted restricted stock units (for use from November 1, 2019).*10-Q001-0442310(q)(q)(q)March 5, 2020
10(t)(t)Amendment Number One to Second Amended and Restated HP Inc. 2004 Stock Incentive Plan (as amended effective February 28, 2020).*10-Q001-0442310(r)(r)(r)June 5, 2020
10(u)(u)Amendment Number One to Registrant’s 2005 Executive Deferred Compensation Plan (as amended effective February 28, 2020).*10-Q001-0442310(s)(s)(s)June 5, 2020
10(v)(v)HP Inc. 2021 Employee Stock Purchase Plan.*10-Q001-0442310(t)(t)(t)June 5, 2020
10(w)(w)Amendment Number Two to Second Amended and Restated HP Inc. 2004 Stock Incentive Plan (as amended effective September 21, 2020.*10-K001-0442310(x)(x)(x)December 10, 2020
10(x)(x)Amendment Number Two to Registrant's 2005 Executive Deferred Compensation Plan (as amended effective September 21, 2020).*10-K001-0442310(y)(y)(y)December 10, 2020
10(y)(y)Form of Grant Agreement for grants of restricted stock units (for use from November 17, 2020).*10-Q001-0442310(x)(x)(x)March 5, 2021
10(z)(z)Form of Retention Grant Agreement for grants of restricted stock units (for use from November 17, 2020).*10-Q001-0442310(y)(y)(y)March 5, 2021
10(a)(a)(a)Form of Grant Agreement for grants of non-qualified stock options.*10-Q001-0442310(z)(z)(z)March 5, 2021
10(b)(b)(b)Form of Retention Grant Agreement for grants of non-qualified stock options.*10-Q001-0442310(a)(a)(a)(a)March 5, 2021
10(c)(c)(c)Form of Grant Agreement for grants of performance-adjusted restricted stock units (for use from November 17, 2020).*10-Q001-0442310(b)(b)(b)(b)March 5, 2021
10(d)(d)(d)Form of Grant Agreement for grants of performance-contingent non-qualified stock options.*10-Q001-0442310(c)(c)(c)(c)March 5, 2021
10(e)(e)(e)Form of Grant Agreement for grants of restricted stock units for directors.*10-Q001-0442310(d)(d)(d)(d)March 5, 2021
10(f)(f)(f)First Amendment to the Registrant’s Severance and Long-Term Incentive Change in Control Plan for Executive Officers, as amended and restated effective February 28, 2020 (as amended effective December 7, 2020)*10-Q001-0442310(e)(e)(e)(e)March 5, 2021
Exhibit NumberIncorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
10(g)(g)(g)Amendment Number Three to Registrant’s 2005 Executive Deferred Compensation Plan (as amended effective November 17, 2020).*10-Q001-0442310(f)(f)(f)(f)March 5, 2021
10(h)(h)(h)Five-Year Credit Agreement, dated as of May 26, 2021, among the Registrant, the lenders named therein and JPMorgan Chase Bank, N.A., as administrative agent.8-K001-0442310.1June 1, 2021
10(i)(i)(i)Amendment Number Four to Registrant’s 2005 Executive Deferred Compensation Plan (as amended effective as of April 1, 2021 and December 31, 2021).*10-Q001-0442310(j)(j)(j)September 3, 2021
10(j)(j)(j)Form of Grant Agreement for grants of restricted stock units (for use from November 16, 2021).*10-Q001-0442310(j)(j)(j)March 7, 2022
10(k)(k)(k)Form of Retention Grant Agreement for grants of restricted stock units (for use from November 16, 2021).*10-Q001-0442310(k)(k)(k)March 7, 2022
10(l)(l)(l)Form of Grant Agreement for grants of non-qualified stock options.*10-Q001-0442310(l)(l)(l)March 7, 2022
10(m)(m)(m)Form of Retention Grant Agreement for grants of non-qualified stock options.*10-Q001-0442310(m)(m)(m)March 7, 2022
10(n)(n)(n)Form of Grant Agreement for grants of performance-adjusted restricted stock units (for use from November 16, 2021).*10-Q001-0442310(n)(n)(n)March 7, 2022
10(o)(o)(o)Form of Grant Agreement for grants of performance-contingent non-qualified stock options.*10-Q001-0442310(o)(o)(o)March 7, 2022
10(p)(p)(p)Third Amended and Restated HP Inc. 2004 Stock Incentive Plan.*8-K001-0442310.1April 22, 2022
10(q)(q)(q)Amendment Agreement, dated August 23, 2022 to the Five-Year Credit Agreement dated May 26, 2021, by and among HP Inc., the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent.8-K001-0442310.1August 26, 2022
10(r)(r)(r)Plantronics, Inc. 2003 Stock Plan, as amended and restated.*S-8333-2671514.4August 29, 2022
10(s)(s)(s)Amendment Number One to the Plantronics, Inc. 2003 Stock Plan, as amended and restated.*S-8333-2671514.5August 29, 2022
10(t)(t)(t)Amendment Number Five to Registrant’s 2005 Executive Deferred Compensation Plan.*10-K001-0442310(t)(t)(t)December 6, 2022
21Subsidiaries of the Registrant as of October 31, 2022.10-K001-0442321December 6, 2022
23Consent of Independent Registered Public Accounting Firm.†
31.1Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.†
31.2Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.†
32Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.††
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.†
Exhibit NumberIncorporated by Reference
Exhibit DescriptionFormFile No.Exhibit(s)Filing Date
101.SCHInline XBRL Taxonomy Extension Schema Document.†
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.†
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.†
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.†
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.†
104The cover page from the Company’s Annual Report on Form 10-K/A for the fiscal year ended October 31, 2022, formatted in Inline XBRL (included within the Exhibit 101 attachments).†
  • Indicates management contract or compensatory plan, contract or arrangement.

** Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Registration S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally to the SEC upon request.

† Filed herewith.

†† Furnished herewith.

The registrant agrees to furnish to the Commission supplementally upon request a copy of (1) any instrument with respect to long-term debt not filed herewith as to which the total amount of securities authorized thereunder does not exceed 10% of the total assets of the registrant and its subsidiaries on a consolidated basis and (2) any omitted schedules to any material agreements set forth above.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: September 11, 2023HP INC.
By:/s/ MARIE MYERS
Marie Myers Chief Financial Officer